Fabrice Le Gall

Person

Mainz, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...
- Patent number 11,787,862
- Issue date Oct 17, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Drug conjugates comprising antibodies against claudin 18.2
- Patent number 11,541,127
- Issue date Jan 3, 2023
- Astellas Pharma, Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents for treatment of claudin expressing cancer diseases
- Patent number 10,717,780
- Issue date Jul 21, 2020
- BioNTech AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents for treatment of claudin expressing cancer diseases
- Patent number 10,093,736
- Issue date Oct 9, 2018
- BioNTech AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD16 binding molecules
- Patent number 9,701,750
- Issue date Jul 11, 2017
- Affimed GMBH
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human CD3-specific antibody with immunosuppressive properties
- Patent number 9,226,962
- Issue date Jan 5, 2016
- Affimed GMBH
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD16 binding molecules
- Patent number 9,035,026
- Issue date May 19, 2015
- Affimed GMBH
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of an antibody against the laminin receptor or laminin receptor...
- Patent number 7,901,677
- Issue date Mar 8, 2011
- Affimed Therapeutics AG
- Melvyn Little
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...
- Publication number 20240158501
- Publication date May 16, 2024
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20230270878
- Publication date Aug 31, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE
- Publication number 20220048994
- Publication date Feb 17, 2022
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20200399370
- Publication date Dec 24, 2020
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...
- Publication number 20190309067
- Publication date Oct 10, 2019
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20190055311
- Publication date Feb 21, 2019
- BIONTECH AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN-BINDING MOLECULE AND USES THEREOF
- Publication number 20180346590
- Publication date Dec 6, 2018
- Affimed GmbBH
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20180117174
- Publication date May 3, 2018
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE
- Publication number 20170037128
- Publication date Feb 9, 2017
- Affimed GmbH
- Melvyn LITTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20160272711
- Publication date Sep 22, 2016
- BIONTECH AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULE AND USES THEREOF
- Publication number 20150225484
- Publication date Aug 13, 2015
- Affimed GmbH
- Melvyn LITTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD16 BINDING MOLECULES
- Publication number 20150218275
- Publication date Aug 6, 2015
- Affimed GmbH
- Karin Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN-BINDING MOLECULE AND USES THEREOF
- Publication number 20130189263
- Publication date Jul 25, 2013
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN CD3-SPECIFIC ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES
- Publication number 20130115213
- Publication date May 9, 2013
- AFFIMED THERAPEUTICS, AG
- Fabrice LE GALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antigen-Binding Molecule And Uses Thereof
- Publication number 20110206672
- Publication date Aug 25, 2011
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-cd16 binding molecules
- Publication number 20090214574
- Publication date Aug 27, 2009
- AFFIMED THERAPEUTICS AG
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY COMBINATION USEFUL FOR TUMOR THERAPY
- Publication number 20080145362
- Publication date Jun 19, 2008
- AFFIMED THERAPEUTICS, AG
- Sergey Kipriyanov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human cd3-specific antibody with immunosuppressive properties
- Publication number 20060233787
- Publication date Oct 19, 2006
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody combination useful for tumor therapy
- Publication number 20050176934
- Publication date Aug 11, 2005
- Sergey Kipriyanov
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific anti-cd19x anti-cd16 antibodies and uses thereof
- Publication number 20050089519
- Publication date Apr 28, 2005
- Sergey Kipriyanov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dimeric and multimeric antigen binding structure
- Publication number 20050079170
- Publication date Apr 14, 2005
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Fabrice Le Gall

Person

Patents Grantslast 30 patents

Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...

Drug conjugates comprising antibodies against claudin 18.2

Agents for treatment of claudin expressing cancer diseases

Agents for treatment of claudin expressing cancer diseases

Anti-CD16 binding molecules

Human CD3-specific antibody with immunosuppressive properties

Anti-CD16 binding molecules

Use of an antibody against the laminin receptor or laminin receptor...

Patents Applicationslast 30 patents

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

Agents for Treatment of Claudin Expressing Cancer Diseases

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...

Agents for Treatment of Claudin Expressing Cancer Diseases

ANTIGEN-BINDING MOLECULE AND USES THEREOF

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

Agents for Treatment of Claudin Expressing Cancer Diseases

ANTIGEN-BINDING MOLECULE AND USES THEREOF

ANTI-CD16 BINDING MOLECULES

ANTIGEN-BINDING MOLECULE AND USES THEREOF

HUMAN CD3-SPECIFIC ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES

Antigen-Binding Molecule And Uses Thereof

Anti-cd16 binding molecules

ANTIBODY COMBINATION USEFUL FOR TUMOR THERAPY

Human cd3-specific antibody with immunosuppressive properties

Antibody combination useful for tumor therapy

Bispecific anti-cd19x anti-cd16 antibodies and uses thereof

Dimeric and multimeric antigen binding structure